These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35470438)

  • 21. Electrophysiology of neuromuscular disorders in critical illness.
    Lacomis D
    Muscle Nerve; 2013 Mar; 47(3):452-63. PubMed ID: 23386582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study.
    Hermans G; Schrooten M; Van Damme P; Berends N; Bouckaert B; De Vooght W; Robberecht W; Van den Berghe G
    Crit Care; 2009; 13(1):R5. PubMed ID: 19166623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired weakness in the ICU: critical illness myopathy and polyneuropathy.
    Khan J; Burnham EL; Moss M
    Minerva Anestesiol; 2006 Jun; 72(6):401-6. PubMed ID: 16682908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome.
    Bercker S; Weber-Carstens S; Deja M; Grimm C; Wolf S; Behse F; Busch T; Falke KJ; Kaisers U
    Crit Care Med; 2005 Apr; 33(4):711-5. PubMed ID: 15818093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intensive care unit-acquired weakness: development of polyneuropathy and myopathy in critically ill patients].
    Takei T
    Brain Nerve; 2014 Feb; 66(2):161-70. PubMed ID: 24523314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fitness and mobility training in patients with Intensive Care Unit-acquired muscle weakness (FITonICU): study protocol for a randomised controlled trial.
    Mehrholz J; Thomas S; Burridge JH; Schmidt A; Scheffler B; Schellin R; Rückriem S; Meißner D; Mehrholz K; Sauter W; Bodechtel U; Elsner B
    Trials; 2016 Nov; 17(1):559. PubMed ID: 27881152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy.
    Kukreti V; Shamim M; Khilnani P
    Indian J Crit Care Med; 2014 Feb; 18(2):95-101. PubMed ID: 24678152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive care unit-acquired weakness: Questions the clinician should ask.
    Tortuyaux R; Davion JB; Jourdain M
    Rev Neurol (Paris); 2022; 178(1-2):84-92. PubMed ID: 34998522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.
    Frithiof R; Rostami E; Kumlien E; Virhammar J; Fällmar D; Hultström M; Lipcsey M; Ashton N; Blennow K; Zetterberg H; Punga AR
    Clin Neurophysiol; 2021 Jul; 132(7):1733-1740. PubMed ID: 33875374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The General Weakness Syndrome Therapy (GymNAST) study: protocol for a cohort study on recovery on walking function.
    Mehrholz J; Mückel S; Oehmichen F; Pohl M
    BMJ Open; 2014 Oct; 4(10):e006168. PubMed ID: 25344484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy.
    Bird SJ
    Curr Treat Options Neurol; 2007 Mar; 9(2):85-92. PubMed ID: 17298769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of critical illness polyneuropathy and/or myopathy - a systematic review.
    Ydemann M; Eddelien HS; Lauritsen AØ
    Dan Med J; 2012 Oct; 59(10):A4511. PubMed ID: 23158890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible tetraplegia after percutaneous nephrostolithotomy and septic shock: a case of critical illness polyneuropathy and myopathy with acute onset and complete recovery.
    Li H; Wu LM; Kong XB; Hou Y; Zhao R; Li HY; Zhang HL
    BMC Nephrol; 2013 Feb; 14():36. PubMed ID: 23409743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Critical illness polyneuropathy and critical illness myopathy].
    Grimm A; Günther A; Witte OW; Axer H
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):649-58; quiz 659. PubMed ID: 23104463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperglycemia and acquired weakness in critically ill patients: potential mechanisms.
    Callahan LA; Supinski GS
    Crit Care; 2009; 13(2):125. PubMed ID: 19439021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical illness-associated weakness and related motor disorders.
    Younger DS
    Handb Clin Neurol; 2023; 195():707-777. PubMed ID: 37562893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical illness polyneuropathy and myopathy in the intensive care unit.
    Zink W; Kollmar R; Schwab S
    Nat Rev Neurol; 2009 Jul; 5(7):372-9. PubMed ID: 19578344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuromuscular manifestations in critically ill patients].
    Smith TA; Fabricius ME
    Ugeskr Laeger; 2007 Jun; 169(23):2216-9. PubMed ID: 17592690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurogenic vs. Myogenic Origin of Acquired Muscle Paralysis in Intensive Care Unit (ICU) Patients: Evaluation of Different Diagnostic Methods.
    Marrero HDJG; Stålberg EV; Cooray G; Corpeno Kalamgi R; Hedström Y; Bellander BM; Nennesmo I; Larsson L
    Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33217953
    [No Abstract]   [Full Text] [Related]  

  • 40. [Critical illness polyneuropathy and myopathy].
    Motomura M
    Rinsho Shinkeigaku; 2003 Nov; 43(11):802-4. PubMed ID: 15152469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.